LONP1 and cancer: Overall, genetic, and pharmacological deactivation of LonP1 was demonstrated to impede physiological processes in both experimental systems (C. elegans and cancer cells) and induced similar stress-responsive transcriptional changes to adapt mitochondrial dysfunction to specific cell stresses or metabolic demands.